ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

NCI CTEP-Approved Trials For the Month of July

July 25, 2014

New Drug Reverses Damage To Liver In Stem Cell Transplant

September 27, 2002

ASCO proposes compromise to limit payment cuts proposed by Congress, CMS.

September 12, 2003

Bernard Fisher Sues Univ. of Pittsburgh And Its Attorney

July 15, 1994

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

NCAB Subcommittee Works On Drafting Quantitative Risk Assessment Policy

October 1, 1982